ArticleOncotarget2016

Targeting p53-deficient chronic lymphocytic leukemia cells in vitro and in vivo by ROS-mediated mechanism.

Jinyun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.